Skip to main content
Log in

The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Introduction

In this study, we have investigated the role of leptin, soluble leptin receptor(sOb-R), resistin, and insulin secretory dynamics in the development of hypothalamic obesity.

Materials and methods

Children who had hypothalamo-pituitary tumor were divided into two groups. First group included obese-overweight (hypothalamic obese = HOB group, n = 23) and second group included non-obese children (hypothalamic non-obese = HNOB group, n = 16). Exogenously obese-overweight children (OB group, n = 22) were included as controls. Basal and second-hour serum glucose and insulin in oral glucose tolerance test (OGTT), basal serum leptin, sOb-R, resistin levels, and homeostasis model assessment (HOMA) indexes were compared between the groups.

Results

Age, sex, and pubertal status were similar in study groups. Median and interquartile ranges of body mass index (BMI) z scores were similar in HOB and OB groups (2.0 (1.5–2.1) and 2.1 (1.8–2.3), respectively). Serum leptin levels corrected for BMI were highest and total leptin/sOb-R ratios (free leptin index (FLI)) tended to be higher in HOB than HNOB and OB groups, indicating leptin resistance (leptin/BMI, 4.0 (1.6–5.2), 1.5 (0.8–3.1), and 2.5 (1.8–3.5); FLI, 2.0 (0.8–3.5), 0.6 (0.3–1.2), and 1.5 (1–2.3) in HOB, HNOB, and OB groups; respectively). Serum resistin levels were similar in groups (2.6 (1.9–3.1), 2.8 (1.7–3.4), and 3.0 (2.2–3.5) ng/ml in HOB, HNOB, and OB groups, respectively). Basal serum glucose, basal and second-hour insulin levels in OGTT, and HOMA index were higher in OB group than the HOB and HNOB groups, indicating insulin resistance in simple obesity; however, increment of insulin to same glycemic load in OGTT was highest in the HOB group indicating insulin dysregulation (p < 0.05).

Conclusion

Hypothalamic obesity seems to be related to both dysregulated afferent (leptin) and efferent (insulin) neural outputs through the autonomic nervous system resulting in energy storage as fat.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

sOb-R:

soluble leptin receptor

HOB:

Hypothalamic obese

HNOB:

Hypothalamic non-obese

OB:

Obese

OGTT:

Oral glucose tolerance test

BMI:

Body mass index

FLI:

Free leptin index

HOMA-IR:

Homeostasis model assessment for insulin resistance index

References

  1. Ainsworth BE, Haskell WL, Leon AS (1993) Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25(1):71–80

    Article  PubMed  CAS  Google Scholar 

  2. American Diabetes Association (2000) Type 2 diabetes in children (consensus statement). Diabetes Care 23(3):381–389

    Article  Google Scholar 

  3. Anderlová K, Kremen J, Dolezalová R (2006) The influence of very-low-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiol Res 55(3):277–283

    PubMed  Google Scholar 

  4. Banerjee RR, Rangwala SM, Shapiro JS (2004) Regulation of fasted blood glucose by resistin. Science 303:1195–1198

    Article  PubMed  CAS  Google Scholar 

  5. Bray GA, York DA (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59(3):719–809

    PubMed  CAS  Google Scholar 

  6. Chanchay S, Tungtrongchitr R, Harnroongroj T (2006) Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai. Int J Vitam Nutr Res 76(3):125–131

    Article  PubMed  CAS  Google Scholar 

  7. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320(7244):1240–1243

    Article  PubMed  CAS  Google Scholar 

  8. Housová J, Anderlová K, Křížová J (2004) Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 90:1366–1370

    Article  PubMed  Google Scholar 

  9. Igaki N, Tanaka M, Goto T (2005) Markedly improved glycemic control and enhanced insulin sensitivity in a patient with type 2 diabetes complicated by a suprasellar tumor treated with pioglitazone and metformin. Intern Med 44(8):832–837

    Article  PubMed  Google Scholar 

  10. Iqbal N, Seshadri P, Stern L (2005) Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci 9(3):161–165

    PubMed  CAS  Google Scholar 

  11. Lammert A, Kiess W, Bottner A (2001) Soluble leptin receptor presents the main leptin binding activity in human blood. Biochem Biophys Res Commun 283:982–988

    Article  PubMed  CAS  Google Scholar 

  12. Lehrke M, Reilly MP, Millington SC (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1:e45

    Article  PubMed  Google Scholar 

  13. Lustig RH (2006) Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the first law of thermodynamics. Nat Clin Pract Endocrinol Metab 2(8):447–458

    Article  PubMed  CAS  Google Scholar 

  14. Lustig RH, Hinds PS, Ringwald-Smith K (2003) Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88(6):2586–2592

    Article  PubMed  CAS  Google Scholar 

  15. Lustig RH, Rose SR, Burghen GA (1999) Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 135(2 Pt 1):162–168

    PubMed  CAS  Google Scholar 

  16. McTernan PG, McTernan CL, Chetty R (2002) Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 87:2407

    Article  PubMed  CAS  Google Scholar 

  17. Muse ED, Lam TK, Scherer PE, Rossetti L (2007) Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest 117(6):1670–1678

    Article  PubMed  CAS  Google Scholar 

  18. Müller HL, Müller-Stöver S, Gebhardt U (2006) Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients. J Pediatr Endocrinol Metab 19(Suppl 1):423–429

    PubMed  Google Scholar 

  19. Pastucha D, Malincíková J, Hyjánek J (2007) Obesity and insulin resistance in childhood. Cent Eur J Public Health 15(3):103–105

    PubMed  Google Scholar 

  20. Patel L, Cooper CD, Quinton ND, Butler GE, Gill MS, Jefferson IG, Kibirige MS, Price DA, Shalet SM, Wales JK, Ross RJ, Clayton PE, Northern Paediatric Endocrine Group, UK (2002) Serum leptin and leptin binding activity in children and adolescents with hypothalamic dysfunction. J Pediatr Endocrinol Metab 15(7):963–971

    PubMed  CAS  Google Scholar 

  21. Proto C, Romualdi D, Cento RM (2007) Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader Willi and the Down syndromes. Metabolism 56(8):1076–1080

    Article  PubMed  CAS  Google Scholar 

  22. Rangwala SM, Rich AS, Rhoades B (2004) Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53(8):1937–1941

    Article  PubMed  CAS  Google Scholar 

  23. Reinehr T, Kratzsch J, Kiess W, Andler W (2005) Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children. Int J Obes (Lond) 29(10):1230–1235

    Article  CAS  Google Scholar 

  24. Rose SR, Schreiber RE, Kearney NS (2004) Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab 17(1):55–66

    PubMed  Google Scholar 

  25. Roth C, Wilken B, Hanefeld F (1998) Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 138(1):89–91

    Article  PubMed  CAS  Google Scholar 

  26. Rutter MM, Rose SR (2007) Long-term endocrine sequelae of childhood cancer. Curr Opin Pediatr 19(4):480–487

    Article  PubMed  Google Scholar 

  27. Shaikh MG, Grundy R, Kirk J (2008) Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children. Eur J Endocrinol, Sep 26 (in press)

  28. Srinivasan S, Ogle GD, Garnett SP (2004) Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89(1):81–86

    Article  PubMed  CAS  Google Scholar 

  29. Tiosano D, Eisentein I, Militianu D (2003) 11 beta-hydroxysteroid dehydrogenase activity in hypothalamic obesity. J Clin Endocrinol Metab 88(1):379–384

    Article  PubMed  CAS  Google Scholar 

  30. Zou CC, Liang L, Hong F (2007) Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity. Indian Pediatr 44(4):275–279

    PubMed  Google Scholar 

Download references

Acknowledgment

The authors would like to thank pediatric dietician Sabiha Keskin for caloric analyses of the children and SERONO Company who provided the commercial kits for serum leptin, soluble leptin receptor, and resistin.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abdullah Bereket.

Additional information

This work has been presented in part in the free communication session of ESPE 2007 meeting (Helsinki-Finland, 2007).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guran, T., Turan, S., Bereket, A. et al. The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children. Eur J Pediatr 168, 1043–1048 (2009). https://doi.org/10.1007/s00431-008-0876-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-008-0876-x

Keywords

Navigation